Cramer’s Diagnostics Pick, Pet Blood & Urine… Really (IDXX)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

On tonight’s MAD MONEY on CNBC, Jim Cramer came out calling for a move toward being ultra-defensive in what he said is a bear market and fed-mandated recession (here’s our own 2008 defensive stocks with a value mix, although these aren’t all stocks you can just buy and hold) in a brutal market where you main goal has to be capital preservation.  Cramer said this is a vicious overreaction to the downside on Intel in after-hours trading.

One sector that Cramer said is very defensive that can still work is a diagnostics company.  One company that has no government reimbursement risk is in pet care and was up today.  IDEXX Laboratories (NASDAQ:IDXX) is his pick.  He thinks you should wait for a pullback and not buy it tomorrow, but it is a buy according to him.  It also has coming catalysts as a replacement for its blood and urine testing and its sales seem stable.  It has come down from highs and he thinks there could be some estimate bump ups on the stock.  IDEXX Labs (IDXX) shares closed up 1.56% today at

Last night on MAD MONEY Cramer also came out and said he was evaluatingEMC Corp. (NYSE: EMC) as his oversold and overlooked tech pick.  Here was his 2007 active list that is still active for 2008 and still has relevance to his calls today.

Jon C. Ogg
January 15, 2008

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618